This topic contains a solution. Click here to go to the answer

Author Question: A person is in cardiac arrest. You cannot open the person's mouth. Which of the following is ... (Read 117 times)

luminitza

  • Hero Member
  • *****
  • Posts: 555
A person is in cardiac arrest. You cannot open the person's mouth. Which of the following is in-dicated?
 
  a. Mouth-to-barrier device breathing
  b. Mouth-to-nose breathing
  c. Mouth-to-stoma breathing
  d. Abdominal thrusts

Question 2

Which type of rescue breathing is used whenever possible?
 
  a. Mouth-to-mouth
  b. Mouth-to-nose
  c. Mouth-to-barrier device
  d. The type the rescuer is most comfortable using



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittanywood

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

B

Answer to Question 2

C




luminitza

  • Member
  • Posts: 555
Reply 2 on: Jul 16, 2018
Gracias!


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

For a complete list of videos, visit our video library